Patients taking edoxoban after heart valve surgery had lower risk of ...

American Heart Association Scientific Sessions 2024, Abstract 4169811 - Edoxaban, a medication taken orally to prevent blood clots from ...

ENBALV: Edoxaban vs. Warfarin Following Bioprosthetic Valve ...

"Edoxaban could make life easier for patients recovering from heart valve surgery. ... risk while still offering effective treatment ...

ENBALV: Edoxaban Matches Warfarin After Bioprosthetic Valve ...

Izumi noted that NOACs have been increasingly used at discharge for patients following bioprosthetic valve replacement “despite this being an ...

American Heart News on X: "Patients taking edoxoban after heart ...

Patients taking edoxoban after heart valve surgery had lower risk of stroke, blood clots #AHA24 https://t.co/IWsIet0y7C.

Efficacy and safety of edoxaban in patients early after surgical ...

Edoxaban is noninferior to warfarin for preventing thromboembolism and is potentially comparable for risk of major bleeding during the first 3 months after ...

Efficacy and Safety of Edoxaban in Anticoagulant Therapy Early ...

Conclusions Edoxaban had comparable efficacy to warfarin for the prevention of thromboembolic events in patients early after bioprosthetic valve ...

Edoxaban Versus Dual Antiplatelet Therapy for Leaflet Thrombosis ...

Conclusions: In patients without an indication for long-term anticoagulation after successful transcatheter aortic valve replacement, the ...

Clinical Trial Efficacy and safety of edoxaban in patients early after ...

Edoxaban is noninferior to warfarin for preventing thromboembolism and is potentially comparable for risk of major bleeding during the first 3 months after ...

Patients treated with edoxaban after TAVR do not find reduction in ...

Patients treated with the blood thinner edoxaban for six months after a heart valve replacement ... after TAVR might reduce patients' risk ...

Edoxaban versus Vitamin K Antagonist for Atrial Fibrillation after TAVR

Atrial fibrillation occurs in approximately 33% of patients after transcatheter aortic-valve replacement (TAVR), and oral anticoagulation is ...

Edoxaban for the Prevention of Thromboembolism in Patients With ...

The edoxaban dose was reduced by 50% in patients with decreased clearance. Patients with a history of left-sided valvular heart disease, ...

Efficacy and safety of edoxaban in patients early after surgical ...

Early warfarin anticoagulation is recommended in patients undergoing surgical bioprosthetic valve implantation or valve repair.

Edoxaban Might Be Effective for Atrial Fibrillation Patients After TAVR

“Atrial fibrillation after transcatheter aortic valve replacement is common, especially among older patients, but there has been little research ...

Edoxaban May Be Alternative to Warfarin After Surgical Valve ...

In the 3 months after an aortic or mitral surgery, the DOAC was protective against thromboembolism and major bleeding.

Clinical Trials - Mayo Foundation for Medical Education and Research

This is called atrial fibrillation. Atrial fibrillation increases the chance of having a heart attack or stroke. Some patients also get new heart valves using a ...

Edoxaban May Be Effective Treatment for Atrial Fibrillation After ...

“Atrial fibrillation after transcatheter aortic valve replacement is common, especially among older patients, but there has been little research ...

Edoxaban noninferior to warfarin for adverse events after heart valve ...

He concluded: “ENVISAGE-TAVI AF suggests that treatment with edoxaban can be valuable in the management of this high-risk population of patients ...

Valvular Heart Disease Patients on Edoxaban or Warfarin in the ...

In patients with VHD, myocardial infarction (1.06%/year vs. 0.74%/year, respectively; HRadj: 1.29; 95% CI: 1.00 to 1.67; p = 0.047), ...

Effect of edoxaban compared with other oral anticoagulants for ...

Dabigatran was correlated to reduced risks of major bleeding and SSE compared with rivaroxaban [ [11]]. Nevertheless, the effect of edoxaban ...

The ADAPT-TAVR Randomized Clinical Trial - AHA Journals

In patients without an indication for long-term anticoagulation after successful transcatheter aortic valve replacement, the incidence of ...